New agency could be bad for health

Serious concerns raised over UK government's haste in setting up new Health Protection Agency.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Monday 16 September sees the deadline for voicing opinions about the Chief Medical Officer's plans for a radical overhaul of the systems that safeguard public health in England and Wales. His aim is to fold four key agencies into one, and experts in public health believe they have cause for concern.

The idea is to amalgamate the Public Health Laboratory Service (PHLS), the National Radiological Protection Board (NRPB), the Centre for Applied Microbiology and Research (CAMR) and the National Focus for Chemical Incidents (NFCI) into a new Health Protection Agency (HPA).

Most experts agree that the current set-up is less than optimal and welcome any attempt to strengthen public health protection. But many are anxious that the pace of change is too fast to be safe — the Chief Medical Officer seems determined to complete the changes by 1 April 2003. The Board of the PHLS believes that, at the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Pete Moore

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio